An in vitro study of the elimination of oseltamivir carboxylate by haemofiltration

被引：9

作者：

Gruber, Pascale C. ^{[1
]}

Tian, Qi ^{[1
]}

Gomersall, Charles D. ^{[1
]}

Joynt, Gavin M. ^{[1
]}

Choi, Gordon Y. S. ^{[1
]}

机构：

[1] Chinese Univ Hong Kong, Dept Anaesthesia & Intens Care, Shatin, Hong Kong, Peoples R China

来源：

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2007年 / 30卷 / 01期

关键词：

D O I：

10.1016/j.ijantimicag.2007.02.013

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：95 / 97

页数：3

共 7 条

[1] Current concepts - Avian influenza A (H5N1) infection in humans [J].

Beigel, H ;

Farrar, H ;

Han, AM ;

Hayden, FG ;

Hyer, R ;

de Jong, MD ;

Lochindarat, S ;

Tien, NTK ;

Hien, NT ;

Hien, TT ;

Nicoll, A ;

Touch, S ;

Yuen, KY .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (13) :1374-1385

[2]

CALVERY TN, 1991, PRINCIPLES PRACTISE, P43

[3] The effect of adsorption, filter material and point of dilution on antibiotic elimination by haemofiltration - An in vitro study of levofloxacin [J].

Choi, G ;

Gomersall, CD ;

Lipman, J ;

Wong, A ;

Joynt, GM ;

Leung, P ;

Ramsay, SJ ;

Ho, OM .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2004, 24 (05) :468-472

[4] Avian influenza (H5N1): implications for intensive care [J].

Gruber, Pascale C. ;

Gomersall, Charles D. ;

Joynt, Gavin M. .

INTENSIVE CARE MEDICINE, 2006, 32 (06) :823-829

[5] Clinical pharmacokinetics of the prodrug oseltamivir and its active metabolite Ro 64-0802 [J].

He, G ;

Massarella, J ;

Ward, P .

CLINICAL PHARMACOKINETICS, 1999, 37 (06) :471-484

[6]

HE G, 1999, 9 EUR C CLIN MICR IN

[7] Development of a high-performance liquid chromatographic-mass spectrometric assay for the specific and sensitive quantification of Ro 64-0802, an anti-influenza drug, and its pro-drug, oseltamivir, in human and animal plasma and urine [J].

Wiltshire, H ;

Wiltshire, B ;

Citron, A ;

Clarke, T ;

Serpe, C ;

Gray, D ;

Herron, W .

JOURNAL OF CHROMATOGRAPHY B, 2000, 745 (02) :373-388

← 1 →